Titan America SA Common Shares (TTAM)
11.68
-2.62 (-18.32%)
NYSE · Last Trade: Nov 5th, 6:12 PM EST
Titan America (TTAM) Q3 2026 Earnings Call Transcriptfool.com
Energy costs and a plant outage squeezed margins despite Keystone's lift.
Via The Motley Fool · November 5, 2026
Titan America Q2 Earnings Call Highlightsmarketbeat.com
Titan America (NYSE:TTAM) reported second-quarter 2026 revenue growth and a modest increase in adjusted EBITDA, as strong Mid-Atlantic demand offset operational disruptions and softer residential construction conditions in Florida.
Revenue rose 9.6% year over year to $471 million, including a $20 m
Via MarketBeat · July 28, 2026
Titan America (NYSE:TTAM) Posts Revenue Beat But EPS Miss in Q2 2026chartmill.com
Via Chartmill · July 28, 2026
Titan America (TTAM) Q1 2026 Earnings Transcriptfool.com
Titan America (TTAM) Q1 2026 Earnings Transcript
Via The Motley Fool · May 6, 2026
Titan America SA (NYSE:TTAM) Q1 2026 Results Mixed as Earnings Miss Overshadow Revenue Growth and Reaffirmed Guidancechartmill.com
Via Chartmill · May 5, 2026
TITAN AMERICA SA (NYSE:TTAM) Reports Mixed Q4 2025 Results, Stock Falls on Revenue and EPS Misschartmill.com
Via Chartmill · March 17, 2026
Titan America (TTAM) Q4 2025 Earnings Transcriptfool.com
Titan America (TTAM) Q4 2025 Earnings Transcript
Via The Motley Fool · March 18, 2026
This Tevogen Bio Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga.com
Via Benzinga · March 4, 2025
Sionna Therapeutics, Titan America Made Public Debuttalkmarkets.com
Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025